[1] |
SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126.
|
[2] |
LIU Wendong, CUI Huanhuan, WANG Xiaohan, SU Xian, WANG Haixue.
Status and thinking of Parmacovigilance regulatory system during clinical trials of the pediatric drug in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1002-1006.
|
[3] |
TAI Jun, YU Miao, ZHANG Lin, LEI Yi, LIU Junting, LI Tao, HUANG Guimin, CHENG Yijing, NIE Xiaolu, WANG Qing.
Active monitoring of adverse reactions related to haemocoagulase agkistrodon for injection in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1011-1016.
|
[4] |
.
Annual report of national adverse drug reaction monitoring (2022)
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 712-719.
|
[5] |
ZHANG Zhiqi, GUO Mingxing, XU Ye, ZHANG Jian, LIN Jun, CUI Xiangli.
One case of tacrolimus-caused reversible posterior leukoencephalopathy syndrome after renal transplantation in children
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 465-468.
|
[6] |
JIA Zhaoguang, XU Wenshuai, JI Li’na, WANG Linlin, ZHAO Li’na, ZHAO Jingquan, MU Xiangdong.
Diagnosis and treatment of mycoplasma pneumoniae pneumonia in children and rational administration of related drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1391-1395.
|
[7] |
PENG Jing, TUO Yali, LI Qiaoling, ZHOU Rong, LI Xinlin, PENG Hui.
Data analysis of adverse events of clobazam among children based on foreign pharmacovigilance safety spontaneous reporting system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1264-1268.
|
[8] |
CAO Xiaoyu, WANG Ying, WANG Jingwen, YANG Ruixia, GE Jie.
Analysis of agranulocytosis in a child induced by vancomycin injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 106-109.
|
[9] |
ZHANG Jingyu, ZHANG Yuanyuan, WANG Jing, MA Bo, LI Wenjuan.
Influencing factors of severe anaphylactic reactions of Yanhuning injections in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1019-1022.
|
[10] |
XUN Xiaoqing, PENG Lingling.
Effects of sodium valproate on children with epilepsy and determinants of blood concentrations
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1027-1029.
|
[11] |
LIU Chang, LIN Huijun, SHEN Hongxia, YAN Meixing.
Analysis of Adverse drug reactions of intravenous medication in pediatric inpatients in a tertiary children's hospital
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 762-766.
|
[12] |
LI Meiyun, TANG Guangliang, CHEN Zhihong, HE Xin, CHEN Shenjue, LI Xin, LIU Lihua.
Analysis of 107 reports of ADR induced by ribavirin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 770-774.
|
[13] |
WANG Xiaofang, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, WEI Changce.
Pharmacovigilance and pharmaceutical care of traditional Chinese medicine based on ancient pediatric literature
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 591-594.
|
[14] |
LI Yan, SUN Chong, LYU Meng, ZHOU Yuxue, MA Shuli.
Adverse drug reactions of cefoperazone sodium and sulbactam sodium in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 537-540.
|
[15] |
TAI Xinjuan, MA Hongfeng, LI Jun, MA Weixing, YAN Yawei.
400 reports on adverse drug reactions associated with antineoplastic drugs
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 541-544.
|